CDX2 and serous adenocarcinoma: On the basis of an evaluation of clinical tissues of ovarian cancer cases, we observed overexpression of CDX2 in ovarian mucinous adenocarcinoma but only weak expression in other histological types, including serous adenocarcinoma, endometrioid adenocarcinoma, and clear cell carcinoma.